US 10314819
Solid state forms of Eluxadoline
granted A61KA61K31/4164A61P
Quick answer
US patent 10314819 (Solid state forms of Eluxadoline) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4164, A61P, A61P1/12